The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 24, 2019

Filed:

Dec. 09, 2014
Applicant:

The Regents of the University of California, Oakland, CA (US);

Inventors:

Rohit Loomba, San Diego, CA (US);

Oswald Quehenberger, San Diego, CA (US);

Aaron Armando, San Diego, CA (US);

Edward A. Dennis, La Jolla, CA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/487 (2006.01); G01N 30/72 (2006.01); G01N 33/92 (2006.01); G01N 33/88 (2006.01); G16B 20/00 (2019.01);
U.S. Cl.
CPC ...
G01N 33/487 (2013.01); G01N 30/7233 (2013.01); G01N 33/88 (2013.01); G01N 33/92 (2013.01); G16B 20/00 (2019.02); G01N 2800/085 (2013.01); Y02A 90/24 (2018.01); Y02A 90/26 (2018.01);
Abstract

The present invention relates to the substantially non-invasive diagnosis of liver disease, especially to enable intervention in the progression of such disease at an early stage. This invention further relates to the use of plasma biomarkers to differentiate nonalcoholic steatohepatitis (NASH) from nonalcoholic fatty liver (NAFL) and non-nonalcoholic fatty liver disease (NAFLD), and normal controls. Specifically, the invention relates to the use of free eicosanoids and other polyunsaturated fatty acid (PUFA) metabolite levels in plasma to differentiate NASH from NAFL and non-NAFLD normal controls.


Find Patent Forward Citations

Loading…